CD8A and neoplasm: (C) Ki-67+ CD4 and CD8 T cells of tumor bearing CCSP-rtTA; TetO-EGFRL858R mice in the absence (−) and presence (+) of erlotinib for 2 weeks or mice taken off doxycycline for 2 weeks.